A high sensitivity assay of UBE3A ubiquitin ligase activity from Dr. Albert Keung’s Lab
A FAST-funded UBE3A activity assay from Dr. Albert Keung’s lab offers a faster, more sensitive tool for measuring and monitoring UBE3A function in Angelman syndrome research.
FAST Italy Hosts Its First Scientific Symposium on Angelman Syndrome
FAST Italy’s first-ever Scientific Symposium drew over 100 attendees and unveiled two new biotech companies, MavriX Bio and CourageAS Bio, advancing gene therapies for Angelman syndrome.
FAST Poland Organized the 1st Polish National Angelman Syndrome Conference
FAST Poland hosted its first National Angelman Syndrome Conference for International Angelman Day, drawing 164 registered guests to explore clinical research, epilepsy, safety, and quality of life for AS families.
International Angelman Day 2025: Round-Up
The global Angelman syndrome community celebrated International Angelman Day through blue illuminations, educational presentations, school activities, and outreach campaigns to raise awareness.
Introducing the Angelman Syndrome Global Community Advisory Board (CAB)
The Angelman Syndrome Alliance introduces its Global Community Advisory Board (CAB), a EURORDIS-trained group of parent advocates from around the world dedicated to representing family voices in Angelman syndrome research, policy, and advocacy.